Lifestance Health - Medicare Mental Health Clinic in Nashua, NH

Lifestance Health is a medicare enrolled mental health clinic (Psychologist - Clinical) in Nashua, New Hampshire. The current practice location for Lifestance Health is 1 Main St, Nashua, New Hampshire. For appointments, you can reach them via phone at (603) 883-0005. The mailing address for Lifestance Health is 1 Main St, Nashua, New Hampshire and phone number is (603) 883-0005.

Lifestance Health is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1144275389. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (603) 883-0005.

Contact Information

Lifestance Health
1 Main St
Nashua
NH 03064
(603) 883-0005
(603) 883-0007

Mental Health Clinic Profile

Full NameLifestance Health
SpecialityPsychologist
Location1 Main St, Nashua, New Hampshire
Authorized Official Name and PositionRyan Pardo (CHIEF LEGAL OFFICER)
Authorized Official Contact4252798500
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Lifestance Health
1 Main St
Nashua
NH 03064-2716

Ph: (603) 883-0005
Lifestance Health
1 Main St
Nashua
NH 03064

Ph: (603) 883-0005

NPI Details:

NPI Number1144275389
Provider Enumeration Date05/24/2006
Last Update Date10/23/2023
Certification Date10/23/2023

Medicare PECOS Information:

Medicare PECOS PAC ID3274523758
Medicare Enrollment IDO20040929000288

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Lifestance Health such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1144275389NPI-NPPES
80003475MedicaidNH

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
101YA0400XCounselor - Addiction (substance Use Disorder) (* (Not Available))Secondary
101YP2500XCounselor - Professional (* (Not Available))Secondary
103G00000XClinical Neuropsychologist (* (Not Available))Secondary
103T00000XPsychologist (* (Not Available))Secondary
103TA0700XPsychologist - Adult Development & Aging (* (Not Available))Secondary
103TC0700XPsychologist - Clinical (* (Not Available))Primary
103TC1900XPsychologist - Counseling (* (Not Available))Secondary
103TC2200XPsychologist - Clinical Child & Adolescent (* (Not Available))Secondary
103TF0000XPsychologist - Family (* (Not Available))Secondary
103TF0200XPsychologist - Forensic (* (Not Available))Secondary
1041C0700XSocial Worker - Clinical (* (Not Available))Secondary
106H00000XMarriage & Family Therapist (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Lifestance Health acts as a billing entity for following providers:
Provider NameGrace A Tallarico
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1518071133
PECOS PAC ID: 1951395896
Enrollment ID: I20040413000821

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameRoger C Cawley
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1982624656
PECOS PAC ID: 5496790008
Enrollment ID: I20050623000964

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJane E Mcgrath
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1134214265
PECOS PAC ID: 1850337718
Enrollment ID: I20050630000358

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NamePatricia A Leary
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1952471096
PECOS PAC ID: 4981640810
Enrollment ID: I20050630000988

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameBonnie A Cloukey
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1831655398
PECOS PAC ID: 9234160151
Enrollment ID: I20050830000587

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameBette Lewicke
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1992757520
PECOS PAC ID: 7113951922
Enrollment ID: I20050921000707

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJudith Lambert
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1023116092
PECOS PAC ID: 2466486105
Enrollment ID: I20050922000580

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameGeorge M Nowak
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1265526024
PECOS PAC ID: 6305864653
Enrollment ID: I20051105000138

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NamePaul E Downey
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1639153026
PECOS PAC ID: 7113946625
Enrollment ID: I20051114001124

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJohanna M Lewis-esquerre
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1518071299
PECOS PAC ID: 6305865684
Enrollment ID: I20051116000189

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAllan E Mendell
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1598704025
PECOS PAC ID: 0547282055
Enrollment ID: I20051228000091

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameNancy D Leblanc
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1740277680
PECOS PAC ID: 7810910346
Enrollment ID: I20060110000943

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCynthia Cahoon
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1386732022
PECOS PAC ID: 4880609239
Enrollment ID: I20060207000550

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameLaura Richman
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1932213535
PECOS PAC ID: 0840205761
Enrollment ID: I20060214000639

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameRichard M Naimark
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1790730471
PECOS PAC ID: 3375550916
Enrollment ID: I20060307000633

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameBonnie A Kanin
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1033223615
PECOS PAC ID: 5395752810
Enrollment ID: I20060308000477

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameLori E Hillard
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1790899532
PECOS PAC ID: 9032126388
Enrollment ID: I20060313000256

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameTeresa M Cadorette
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1659322238
PECOS PAC ID: 4880602366
Enrollment ID: I20060324000164

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameMichael F Magee
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1750374559
PECOS PAC ID: 5395753842
Enrollment ID: I20060327000050

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJames R Kates
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1760565600
PECOS PAC ID: 8527076074
Enrollment ID: I20060327000101

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJulie H Marsden
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1932118825
PECOS PAC ID: 1658374376
Enrollment ID: I20060819000011

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameSari E Lessard
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1124073564
PECOS PAC ID: 9739182379
Enrollment ID: I20060821000167

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameDavid G Kamen
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1316041700
PECOS PAC ID: 9638174543
Enrollment ID: I20061011000201

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCarol A Drouin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1033208376
PECOS PAC ID: 0941207930
Enrollment ID: I20061106000178

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameLisa A Higgins
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1598830762
PECOS PAC ID: 7618070467
Enrollment ID: I20070315000096

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameChristina A Tempesta
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1063554319
PECOS PAC ID: 2466553433
Enrollment ID: I20070720000106

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameDaniel C Williams
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1972696078
PECOS PAC ID: 7517054661
Enrollment ID: I20071106000492

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameColette L Dumont
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1063467041
PECOS PAC ID: 4688751878
Enrollment ID: I20080412000023

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameSusan R Kelly
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1659368595
PECOS PAC ID: 0143309492
Enrollment ID: I20080512000447

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameSreenivas Katragadda
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1972698850
PECOS PAC ID: 9436257466
Enrollment ID: I20081028000367

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameVictoria A Gorveatt
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1720129406
PECOS PAC ID: 5193750123
Enrollment ID: I20081114000323

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameMartha Dunn
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1730334343
PECOS PAC ID: 2769547405
Enrollment ID: I20090213000027

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameRebecca K Sartor
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1073750758
PECOS PAC ID: 4688719651
Enrollment ID: I20100302000208

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAlmos I Nagy
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1184848467
PECOS PAC ID: 6507998788
Enrollment ID: I20100723000421

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameHeather Andonucci Hill
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1285959577
PECOS PAC ID: 6709918899
Enrollment ID: I20100726000482

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameSarah Walsh
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1295843175
PECOS PAC ID: 2668664715
Enrollment ID: I20101007000291

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCarrie Gray
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1487847786
PECOS PAC ID: 1254526577
Enrollment ID: I20101112000344

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameBeth Connolly
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1972641306
PECOS PAC ID: 8022299478
Enrollment ID: I20110218000287

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameDavid A Schmidt
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1184774184
PECOS PAC ID: 9133218159
Enrollment ID: I20110510000489

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameTheresa M Bensew
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1598978827
PECOS PAC ID: 0244402634
Enrollment ID: I20111006000632

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAlisa R Hurwitz
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1629244066
PECOS PAC ID: 0042484594
Enrollment ID: I20111117000589

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NamePaul K Broder
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1780798546
PECOS PAC ID: 6103083233
Enrollment ID: I20120201000586

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameDanielle K Palmer
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1386875706
PECOS PAC ID: 2567629561
Enrollment ID: I20120202000448

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameErin E Gilligan
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1356520589
PECOS PAC ID: 6204086507
Enrollment ID: I20121023000192

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameBrian J Taracena
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1730129883
PECOS PAC ID: 6709865231
Enrollment ID: I20121026000130

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJennifer Lee Gaudreau
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1417245374
PECOS PAC ID: 5496788598
Enrollment ID: I20140403000121

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameRichard I Carey
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1881820355
PECOS PAC ID: 4284772005
Enrollment ID: I20140516000805

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameRichard C Tomb
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1902846447
PECOS PAC ID: 7618923202
Enrollment ID: I20150123000948

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJillian Clark
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1609272764
PECOS PAC ID: 7719208107
Enrollment ID: I20150611000099

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameShannon Rose
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1093107211
PECOS PAC ID: 9436460599
Enrollment ID: I20150617000108

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameSylvia A Bradd
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1013174119
PECOS PAC ID: 2567775158
Enrollment ID: I20150727000675

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameRobert Sloane Franklin
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1467769786
PECOS PAC ID: 3375858459
Enrollment ID: I20150819006306

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameLori Eaton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1720331846
PECOS PAC ID: 3173748977
Enrollment ID: I20151118002869

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameThor Agustsson
Provider TypePractitioner - Geriatric Psychiatry
Provider IdentifiersNPI Number: 1427219948
PECOS PAC ID: 2860660453
Enrollment ID: I20151210000436

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameKate E Vaillancourt
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1134289788
PECOS PAC ID: 2567763741
Enrollment ID: I20151211001507

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCheryl Withka
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1023233053
PECOS PAC ID: 7911208111
Enrollment ID: I20151211002068

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameMaryanne F Fournier
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1629381579
PECOS PAC ID: 5395985956
Enrollment ID: I20160325000218

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameLori Little
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1790147148
PECOS PAC ID: 1052605078
Enrollment ID: I20160812001640

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJessica M Leonard
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1033666953
PECOS PAC ID: 6709174550
Enrollment ID: I20161011000139

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameElizabeth A Brenden
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1003938267
PECOS PAC ID: 6709031545
Enrollment ID: I20170419001832

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameMarc Cortino
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1689041485
PECOS PAC ID: 0244597656
Enrollment ID: I20171120001382

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameErika B Ebert
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1598080327
PECOS PAC ID: 0345500237
Enrollment ID: I20180215000142

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCorneliu N Stanciu
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1902244957
PECOS PAC ID: 6103115746
Enrollment ID: I20180827000260

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameBryan Vogel
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1912313305
PECOS PAC ID: 8123371689
Enrollment ID: I20181030002689

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameStephanie L Desmarais
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1427323153
PECOS PAC ID: 1557615523
Enrollment ID: I20181109000633

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAnita D Freeman
Provider TypePractitioner - Certified Clinical Nurse Specialist (cns)
Provider IdentifiersNPI Number: 1952498354
PECOS PAC ID: 2466498837
Enrollment ID: I20181115000360

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NamePavlina Monova
Provider TypePractitioner - Certified Clinical Nurse Specialist (cns)
Provider IdentifiersNPI Number: 1619208006
PECOS PAC ID: 4789712605
Enrollment ID: I20181126000447

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCaroline C Belt
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1447528716
PECOS PAC ID: 2466792668
Enrollment ID: I20190326002454

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJoseph Samuel Insler
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1861780470
PECOS PAC ID: 1658590286
Enrollment ID: I20190401001251

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameColleen D Chausse
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1225498900
PECOS PAC ID: 3476841792
Enrollment ID: I20190409001822

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameNancy Colburn
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1063487064
PECOS PAC ID: 9335192152
Enrollment ID: I20190522002559

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAmy Thomas
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1194754796
PECOS PAC ID: 0042273781
Enrollment ID: I20190618000981

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameMichelle E Ronayne
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1073883716
PECOS PAC ID: 0547596264
Enrollment ID: I20190801001474

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameChad R Saint Amant
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1619526423
PECOS PAC ID: 3971835703
Enrollment ID: I20191029001148

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameWilliam E Fahey
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1316037658
PECOS PAC ID: 0648346320
Enrollment ID: I20191203001511

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameDavid C Dimoplon
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1750440921
PECOS PAC ID: 7416045786
Enrollment ID: I20200108002454

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameNikhil Teja
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1063866903
PECOS PAC ID: 6800224734
Enrollment ID: I20200306002344

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameRamona Smith
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1659932879
PECOS PAC ID: 3577993229
Enrollment ID: I20200420002373

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameRebecca Richards
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1033666359
PECOS PAC ID: 5799063087
Enrollment ID: I20200716002147

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameDonna Primera
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1508879800
PECOS PAC ID: 1759340284
Enrollment ID: I20221007002504

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJulia E Twaddle
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1629343744
PECOS PAC ID: 1759734577
Enrollment ID: I20240129002219

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameTania Osborn-fiandaca
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1386071694
PECOS PAC ID: 3577916105
Enrollment ID: I20240130002253

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameMarianne L Wilson
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1487929253
PECOS PAC ID: 3173976727
Enrollment ID: I20240130002919

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAndrea C Rothberg
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1851674063
PECOS PAC ID: 4981057460
Enrollment ID: I20240131004018

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameErika Freese Wilson
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1053723056
PECOS PAC ID: 7810113503
Enrollment ID: I20240201001030

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameLeanna Lynn Stockard
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1225576150
PECOS PAC ID: 8325491723
Enrollment ID: I20240201003019

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJoan Staigers Haley
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1699876490
PECOS PAC ID: 0345683629
Enrollment ID: I20240205000972

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameRachel Mcleod
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1104285477
PECOS PAC ID: 9537502661
Enrollment ID: I20240206002421

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameKevan Wesley Walker
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1558691105
PECOS PAC ID: 1456795533
Enrollment ID: I20240216000700

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAlexandra Crosby
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1306249123
PECOS PAC ID: 3779927686
Enrollment ID: I20240220000438

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJill Waite
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1992130116
PECOS PAC ID: 7810331683
Enrollment ID: I20240220002983

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJordyn Deschene
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1629782313
PECOS PAC ID: 9739523523
Enrollment ID: I20240220003758

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAmanda M Artz
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1427323542
PECOS PAC ID: 4385088970
Enrollment ID: I20240222002081

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCarol Ann Bates
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1720173107
PECOS PAC ID: 9537503123
Enrollment ID: I20240222002157

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameKimberly M Krasowski
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1124605480
PECOS PAC ID: 8921443235
Enrollment ID: I20240227000496

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAmanda Lena-marlow Dibiasie
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1871919365
PECOS PAC ID: 7810332129
Enrollment ID: I20240227000609

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameStacey A Lanza Roberts
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1083998298
PECOS PAC ID: 3971948290
Enrollment ID: I20240227001117

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAshley Ferm
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1235529553
PECOS PAC ID: 4183069412
Enrollment ID: I20240227001400

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCourtney Keefe
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1699266825
PECOS PAC ID: 4789029018
Enrollment ID: I20240227001497

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameNathaniel Michael Burrow
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1669998894
PECOS PAC ID: 5395180632
Enrollment ID: I20240227001658

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJames Duffy
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1912919127
PECOS PAC ID: 2365887619
Enrollment ID: I20240227002182

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAshley Mcinnis
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1841966850
PECOS PAC ID: 3274978432
Enrollment ID: I20240227002971

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameTammy Anne Nicholson
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1891088274
PECOS PAC ID: 7911342159
Enrollment ID: I20240228000956

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameTiffany Considine
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1649507955
PECOS PAC ID: 2466897616
Enrollment ID: I20240228001346

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameSarah Higgins
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1194956441
PECOS PAC ID: 5597100644
Enrollment ID: I20240228001605

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameJill Pearl
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1922415918
PECOS PAC ID: 9032554100
Enrollment ID: I20240228002426

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameDeborah D Clark
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1245552579
PECOS PAC ID: 2668817735
Enrollment ID: I20240228002483

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameElizabeth Tamietti
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1982010070
PECOS PAC ID: 5092150193
Enrollment ID: I20240228003359

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameSteve Pierog
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1457792756
PECOS PAC ID: 0446695548
Enrollment ID: I20240228003368

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCatherine Eleni Moore
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1003146697
PECOS PAC ID: 0244675239
Enrollment ID: I20240229002048

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameCandace Ann Iannotti
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1275065542
PECOS PAC ID: 9133564727
Enrollment ID: I20240305003875

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameKrystal N Caney
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1659897510
PECOS PAC ID: 9234575242
Enrollment ID: I20240313001399

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameLucille M Care
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1396264818
PECOS PAC ID: 3476999392
Enrollment ID: I20240313002382

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

Provider NameAmy Pierce
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1336483189
PECOS PAC ID: 8224264627
Enrollment ID: I20240315001029

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more Medical News

› Verified 4 days ago

News Archive

Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene

Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations.

Alimera announces FDA approval of ILUVIEN for treatment of diabetic macular edema

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration has approved ILUVIEN for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

NCQA awards Commendable Accreditation to Centene's Florida subsidiary, Sunshine Health

Centene Corporation today announced that its wholly-owned Florida subsidiary, Sunshine Health, was elevated to Commendable Accreditation by the National Committee for Quality Assurance (NCQA) for its Medical Managed Assistance and Child Welfare programs.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

California Institute chemistry professor receives ACS award for 'ultrafast-motion' imaging

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, today will receive the 2011 Priestley Medal, the highest honor bestowed by the American Chemical Society, the world's largest scientific society.

Read more News

› Verified 4 days ago

Psychologist in Nashua, NH

The Youth Council
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 74 Northeastern Blvd Ste 10a, Nashua, NH 03062
Phone: 603-889-1090    Fax: 603-598-1703
Meghan Slaalien Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 154 Broad St Ste 1511, Nashua, NH 03063
Phone: 603-557-5551    
Health & Education Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 34 Lake St, Nashua, NH 03060
Phone: 978-620-1773    
Cheryl A Carroll
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3b Taggart Dr, Nashua, NH 03060
Phone: 978-496-9276    
Gray Area, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 505 W Hollis St Ste 210, Nashua, NH 03062
Phone: 802-490-3916    
Family Counseling Associates Of New Hampshire
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1 Tara Blvd Ste 200, Nashua, NH 03062
Phone: 603-242-2296    
Ann M Rubinstein Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 154 Broad St, Suite 1535, Nashua, NH 03063
Phone: 603-546-0297    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.